The University of Texas M. D. Anderson Cancer Center
Houston, Texas, 77030, United States
Location contact
Lorna McNeill, MPH,PHD
CONTACT
Lorna McNeill, MPH,PHD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT07105020
This trial is aimed to better understand the impact of migration history on the quality of life of Black immigrant CaP survivors (both SSAI and CI). We will illuminate the full range of racial, social, environmental, behavioral, and structural factors associated with the Black immigrant experience in the US using a SDOH model.
Trial opening soon.
Get Notified18 year and older
Male
Interventional
Not applicable
Houston, Texas, 77030, United States
Lorna McNeill, MPH,PHD
CONTACT
Lorna McNeill, MPH,PHD
PRINCIPAL_INVESTIGATOR
Primary Objective:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Interviews will be conducted in person, over the phone, or via Zoom.
Time frame: Through study completion; an average of 1 year
Incidence of Adverse Events, Graded According to National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE) Version (v) 5.0
Contact information is provided by the study sponsor or research team.
M.D. Anderson Cancer Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07574541
Adenocarcinoma, Carcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT07686380
Genital Diseases, Genital Diseases, Male
Bethesda, Maryland, United States
View Trial DetailsNCT07667400
Adenocarcinoma, Adenoid Cystic Carcinoma
Bethesda, Maryland, United States
View Trial DetailsNCT07737925
Genital Diseases, Genital Diseases, Male
View Trial Details